The 2009 BRD Symposium was held Aug. 5-6 in Colorado Springs, Colo. Below are featured videos from the sympsosium, as well as summaries of the presentations. Conference organizer Amelia Woolums, DVM, PhD, University of Georgia, says there were more than 200 veterinarians and researchers in attendance.
NEW! Visit www.brdsymposium.org to view Power Points of selected
presentations from the conference and for information on ordering
copies of the full proceedings.
click below to upgrade to the latest version of Flash.
Update on viral pathogenesis in BRD
By Drovers/Bovine Veterinarian staff
| Friday, August 07, 2009
BHV-1 and BRSV are very different viruses with very different lifestyles within infected cells. Yet, both viruses cause necrosis and/or programmed death in infected cells, stimulate the innate immune system to secrete proinflammatory cytokines, and mediate potentially immunosuppressive effects, says
A characteristic feature of BHV-1 (an alphaherpesvirus) is latency, primarily in neurons in sensory ganglia of the head, notably the trigeminal ganglion, but also probably in other tissues, such as tonsils. Reactivation of latent virus is thought to be a critical event in the transmission of the virus and maintenance of the virus in cattle populations. This phenomenon accounts for BHV-1 outbreaks in the absence of acute infection, i.e. in a “closed herd” or in a pen of feedlot cattle derived from the same ranch.
Cattle with uncomplicated BHV-1 infections have upper respiratory disease of variable severity that can resolve in 7 to 10 days. In many, if not most BHV-1-associated BRD cases, there is a mixed infection with bacteria, notably M. hemolytica and/or P. multocida, that results in severe lower respiratory tract disease.
BRSV is a representative of the Pneumoviriane (Paramyxoviridae) group that cause similar lower respiratory tract diseases in a wide range of host species. There is evidence of persistence, or long term carriage of the virus in some animals.
As with BHV-1, loss of ciliated cells in BRSV-infected airways could account for the disruption of the normal non-specific defense mechanism of mucocilary escalator function, and result in deposition of bacteria in the lower respiratory tract. This could contribute significantly to secondary bacterial bronchopneumonia typical BRD.
